Armstrong Henry H Associates Inc. trimmed its position in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 0.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 373,664 shares of the company's stock after selling 2,234 shares during the quarter. Procter & Gamble accounts for approximately 6.2% of Armstrong Henry H Associates Inc.'s investment portfolio, making the stock its 4th biggest position. Armstrong Henry H Associates Inc.'s holdings in Procter & Gamble were worth $63,680,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Cladis Investment Advisory LLC raised its position in Procter & Gamble by 5.2% in the 4th quarter. Cladis Investment Advisory LLC now owns 4,807 shares of the company's stock valued at $806,000 after purchasing an additional 236 shares in the last quarter. FAS Wealth Partners Inc. raised its position in Procter & Gamble by 2.0% in the 4th quarter. FAS Wealth Partners Inc. now owns 27,690 shares of the company's stock valued at $4,642,000 after purchasing an additional 549 shares in the last quarter. Berkshire Asset Management LLC PA raised its position in Procter & Gamble by 0.9% in the 4th quarter. Berkshire Asset Management LLC PA now owns 236,616 shares of the company's stock valued at $38,833,000 after purchasing an additional 2,179 shares in the last quarter. Strategic Advisors LLC raised its position in Procter & Gamble by 3.4% in the 4th quarter. Strategic Advisors LLC now owns 55,912 shares of the company's stock valued at $9,374,000 after purchasing an additional 1,818 shares in the last quarter. Finally, Richard C. Young & CO. LTD. raised its position in Procter & Gamble by 2.1% in the 4th quarter. Richard C. Young & CO. LTD. now owns 123,853 shares of the company's stock valued at $20,764,000 after purchasing an additional 2,568 shares in the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In other news, CEO Jennifer L. Davis sold 1,000 shares of the business's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total value of $161,380.00. Following the transaction, the chief executive officer now owns 51,965 shares of the company's stock, valued at approximately $8,386,111.70. The trade was a 1.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of the business's stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $158.67, for a total value of $1,669,208.40. Following the completion of the transaction, the insider now directly owns 25,182 shares in the company, valued at approximately $3,995,627.94. The trade was a 29.47% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.18% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on the company. JPMorgan Chase & Co. reduced their price target on Procter & Gamble from $181.00 to $172.00 and set an "overweight" rating on the stock in a research report on Friday, April 11th. Redburn Atlantic lowered Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 price target on the stock. in a research report on Thursday, May 1st. Bank of America reduced their price target on Procter & Gamble from $190.00 to $180.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Redburn Partners set a $161.00 price target on Procter & Gamble in a research report on Thursday, May 1st. Finally, Truist Financial cut their target price on Procter & Gamble from $185.00 to $180.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Eight research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $178.52.
Get Our Latest Stock Report on Procter & Gamble
Procter & Gamble Stock Performance
PG traded down $2.24 during trading on Monday, hitting $167.65. 7,573,563 shares of the stock were exchanged, compared to its average volume of 7,309,644. The firm has a market capitalization of $393.06 billion, a P/E ratio of 26.70, a PEG ratio of 3.76 and a beta of 0.41. The Procter & Gamble Company has a 1-year low of $156.58 and a 1-year high of $180.43. The stock has a fifty day moving average price of $164.35 and a two-hundred day moving average price of $167.40. The company has a quick ratio of 0.55, a current ratio of 0.76 and a debt-to-equity ratio of 0.50.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The company reported $1.54 EPS for the quarter, topping the consensus estimate of $1.53 by $0.01. The company had revenue of $19.78 billion for the quarter, compared to analyst estimates of $20.42 billion. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The firm's revenue was down 2.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.52 earnings per share. As a group, sell-side analysts predict that The Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Monday, April 21st were issued a $1.0568 dividend. The ex-dividend date was Monday, April 21st. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.52%. This is a positive change from Procter & Gamble's previous quarterly dividend of $1.01. Procter & Gamble's payout ratio is presently 66.98%.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report